Fred Hutch Cancer Center
Facts
- HQ
- Puget Sound
- Sectors
- Medical research, Cancer research, Healthcare
Marc Whitten, ex-Microsoft Xbox exec, named president and CEO of Dolby Laboratories as Kevin Yeaman retires
Marc Whitten, a veteran of Microsoft, Sonos, Amazon, Unity, Cruise and Meta, was named president and CEO of Dolby Laboratories, succeeding longtime leader Kevin Yeaman. Fred Hutch announced leadership changes naming Dr. Lawrence Fong as senior VP and director of Translational Science and Dr. Andrew Hsieh as the inaugural endowed chair, and Microsoft AI saw executive departures including CMO Andréa Mallard.
Adaptive Biotechnologies’ Spinout Digital Biotechnologies Raises $15M Series A to Develop Clinical DNA Sequencing Instrument
Digital Biotechnologies, a Seattle-based subsidiary of Adaptive Biotechnologies, has raised up to $15 million in a Series A round to develop a novel clinical DNA sequencing technology. Adaptive will retain nearly half ownership as Digital Biotechnologies aims to create a high-accuracy, rapid, low-cost sequencing instrument for clinical use.
The Future of Biology Is Generative: Inside Synthesize Bio's RNA AI Model
In this episode of Founded & Funded, Madrona Investor Joe Horsman sits down with Jeff Leek and Rob Bradley, co-founders of Synthesize Bio, a foundation model company for biology that's unlocking experiments researchers could never run in the lab. Jeff, chief data officer at the Fred Hutch Cancer Center, and Rob, the McIlwain Family endowed chair in data science, share: •Why a startup the right fit for generative genomics •How generative genomics could reshape research, drug trials, and more •Why RNA is the right starting point for a generative AI model in biology •What this breakthrough means for the future…
